Pfizer Results Hurt by Pricing Challenges - The Wall Street Journal

Pfizer Results Hurt by Pricing Challenges  The Wall Street Journal

Pfizer reported a fourth-quarter loss as the pharmaceutical company faced pricing challenges in the U.S. and tougher generic competition.



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases